These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29693745)

  • 1. Human APOBEC3B interacts with the heterogenous nuclear ribonucleoprotein A3 in cancer cells.
    Mishra N; Reddy KS; Timilsina U; Gaur D; Gaur R
    J Cell Biochem; 2018 Aug; 119(8):6695-6703. PubMed ID: 29693745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1.
    McCann JL; Klein MM; Leland EM; Law EK; Brown WL; Salamango DJ; Harris RS
    J Biol Chem; 2019 Aug; 294(32):12099-12111. PubMed ID: 31217276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B.
    Chen Y; Shen B; Zheng X; Long Q; Xia J; Huang Y; Cai X; Wang D; Chen J; Tang N; Huang A; Hu Y
    Emerg Microbes Infect; 2020; 9(1):366-377. PubMed ID: 32056513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression.
    Zhang W; Zhang X; Tian C; Wang T; Sarkis PT; Fang Y; Zheng S; Yu XF; Xu R
    Cell Microbiol; 2008 Jan; 10(1):112-21. PubMed ID: 17672864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.
    Akre MK; Starrett GJ; Quist JS; Temiz NA; Carpenter MA; Tutt AN; Grigoriadis A; Harris RS
    PLoS One; 2016; 11(5):e0155391. PubMed ID: 27163364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ILF2 enhances the DNA cytosine deaminase activity of tumor mutator APOBEC3B in multiple myeloma cells.
    Kazuma Y; Shirakawa K; Tashiro Y; Yamazaki H; Nomura R; Horisawa Y; Takeuchi S; Stanford E; Konishi Y; Matsui H; Matsumoto T; Tanabe F; Morishita R; Ito S; Takaori-Kondo A
    Sci Rep; 2022 Feb; 12(1):2278. PubMed ID: 35145187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOBEC3B Potently Restricts HIV-2 but Not HIV-1 in a Vif-Dependent Manner.
    Bandarra S; Miyagi E; Ribeiro AC; Gonçalves J; Strebel K; Barahona I
    J Virol; 2021 Nov; 95(23):e0117021. PubMed ID: 34523960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B.
    Hou S; Silvas TV; Leidner F; Nalivaika EA; Matsuo H; Kurt Yilmaz N; Schiffer CA
    J Chem Theory Comput; 2019 Jan; 15(1):637-647. PubMed ID: 30457868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOBEC3B Nuclear Localization Requires Two Distinct N-Terminal Domain Surfaces.
    Salamango DJ; McCann JL; Demir Ö; Brown WL; Amaro RE; Harris RS
    J Mol Biol; 2018 Aug; 430(17):2695-2708. PubMed ID: 29787764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells.
    Periyasamy M; Singh AK; Gemma C; Kranjec C; Farzan R; Leach DA; Navaratnam N; Pálinkás HL; Vértessy BG; Fenton TR; Doorbar J; Fuller-Pace F; Meek DW; Coombes RC; Buluwela L; Ali S
    Nucleic Acids Res; 2017 Nov; 45(19):11056-11069. PubMed ID: 28977491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells.
    Maruyama W; Shirakawa K; Matsui H; Matsumoto T; Yamazaki H; Sarca AD; Kazuma Y; Kobayashi M; Shindo K; Takaori-Kondo A
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1466-71. PubMed ID: 27577680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B.
    Vieira VC; Leonard B; White EA; Starrett GJ; Temiz NA; Lorenz LD; Lee D; Soares MA; Lambert PF; Howley PM; Harris RS
    mBio; 2014 Dec; 5(6):. PubMed ID: 25538195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.
    Cheng AZ; Moraes SN; Attarian C; Yockteng-Melgar J; Jarvis MC; Biolatti M; Galitska G; Dell'Oste V; Frappier L; Bierle CJ; Rice SA; Harris RS
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation.
    Xiao X; Yang H; Arutiunian V; Fang Y; Besse G; Morimoto C; Zirkle B; Chen XS
    Nucleic Acids Res; 2017 Jul; 45(12):7494-7506. PubMed ID: 28575276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC3B promotes hepatocarcinogenesis and metastasis through novel deaminase-independent activity.
    Ma W; Ho DW; Sze KM; Tsui YM; Chan LK; Lee JM; Ng IO
    Mol Carcinog; 2019 May; 58(5):643-653. PubMed ID: 30575099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation.
    Matsumoto T; Shirakawa K; Yokoyama M; Fukuda H; Sarca AD; Koyabu S; Yamazaki H; Kazuma Y; Matsui H; Maruyama W; Nagata K; Tanabe F; Kobayashi M; Shindo K; Morishita R; Sato H; Takaori-Kondo A
    Sci Rep; 2019 Jun; 9(1):8307. PubMed ID: 31165764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B.
    Shi K; Demir Ö; Carpenter MA; Wagner J; Kurahashi K; Harris RS; Amaro RE; Aihara H
    Sci Rep; 2017 Dec; 7(1):17415. PubMed ID: 29234087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3B.
    Roelofs PA; Goh CY; Chua BH; Jarvis MC; Stewart TA; McCann JL; McDougle RM; Carpenter MA; Martens JW; Span PN; Kappei D; Harris RS
    Elife; 2020 Sep; 9():. PubMed ID: 32985974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary mucosal melanomas of the head and neck are characterised by overexpression of the DNA mutating enzyme APOBEC3B.
    Argyris PP; Naumann J; Jarvis MC; Wilkinson PE; Ho DP; Islam MN; Bhattacharyya I; Gopalakrishnan R; Li F; Koutlas IG; Giubellino A; Harris RS
    Histopathology; 2023 Mar; 82(4):608-621. PubMed ID: 36416305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.
    Byeon IJ; Byeon CH; Wu T; Mitra M; Singer D; Levin JG; Gronenborn AM
    Biochemistry; 2016 May; 55(21):2944-59. PubMed ID: 27163633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.